| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 64,254 | 17,192 | 29,734 | 54,839 | | Cost of Revenue | 56,892 | 14,501 | 25,015 | 43,515 | | | Gross Profit | 7,362 | 2,691 | 4,719 | 11,324 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,073 | 533 | 5,749 | 13,291 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,289 | 2,158 | (1,030) | (1,967) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (33) | 136 | (642) | (3,966) | | Earnings Before Interest And Taxes | 6,477 | 2,477 | (1,932) | (8,050) | | Interest Expense | 1,646 | 726 | 878 | 1,062 | | Income Before Tax | 4,831 | 1,751 | (2,810) | (9,112) | | Income Tax Expense | 1,474 | 835 | (859) | (3,357) | | Minority Interest | (195) | (622) | 622 | 1,086 | | | | Net Income From Continuing Ops | 3,357 | 294 | (1,329) | (4,669) | | | Non-recurring Events | | Discontinued Operations | (70) | (274) | (402) | (710) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,092 | 20 | (1,731) | (5,379) | | Preferred Stock And Other Adjustments | (817) | 817 |
-
|
-
| | | Net Income Applicable To Common Shares | $2,275 | $837 | ($1,731) | ($5,379) |
|
0.03% Nasdaq 
Income Statement
